KRS 217.819: Nonequivalent drug product formulary -- Distribution and revision.

(1) The board shall prepare by regulation a nonequivalent drug product formulary of

drugs with their generic names for which there are no equivalent drug products, and

which should not be interchanged by pharmacists. The nonequivalent drug product

formulary sh all list all drugs, drug products, and dosage formulations that the

United States Food and Drug Administration has determined to be therapeutically

nonequivalent.

(2) The board shall provide for annual distribution of copies of such formulary and

revisions and additions thereto among pharmacies licensed within the

Commonwealth and shall supply a copy to any person on request upon payment of

the price established by the board. Such formulary shall be revised and distributed

as often as new and pertinent info rmation on drugs, drug products, and dosage

formulations becomes available from the United States Food and Drug

Administration.